GFP Specific Neutra™ Antibody Products

Are you struggling with inconsistent fluorescent tagging, low target visibility, or inefficient protein tracking in live-cell imaging? Creative Biolabs' GFP specific Neutra™ antibodies employ advanced epitope mapping and affinity maturation technologies to ensure high-precision neutralization of green fluorescent protein (GFP), enabling robust experimental outcomes in dynamic protein studies and therapeutic development.

Introduction to GFP

GFP, found in the jellyfish Aequorea victoria, revolutionized biomedical research as an intrinsic fluorescent biomarker. Its ability to emit visible green light upon excitation eliminates the need for exogenous substrates, making it indispensable for real-time visualization of cellular processes. GFP's autocatalytic chromophore formation and stability across pH variations allow seamless integration into diverse biological systems, from bacterial models to mammalian cells.

• Structural Insights

GFP comprises 238 amino acids folded into an 11-stranded β-barrel structure, encapsulating a central α-helix containing the chromophore. This rigid tertiary structure shields the chromophore from environmental quenching while permitting controlled fluorescence. Mutagenesis studies have yielded variants (e.g., EGFP, mCherry) with enhanced brightness, photostability, and spectral properties, expanding applications in multicolor imaging and protein interaction analysis.

Fig.1 Structure of GFP and chromophore.¹

• Associated Signaling Pathways

GFP's utility extends to mapping cellular signaling cascades. Fusion proteins with GFP-tagged kinases, receptors, or transcription factors enable real-time tracking of pathway activation. For example, GFP-linked NF-κB or MAPK reporters illuminate dynamic responses to inflammatory stimuli, while GFP-based calcium indicators (e.g., GCaMP) monitor neuronal activity with millisecond precision.

• Role in Disease

GFP-tagged viral vectors (e.g., lentiviruses) trace infection pathways, while GFP-labeled tumor cells monitor metastasis in vivo. In neurodegenerative research, GFP-fused tau or α-synuclein proteins visualize aggregation kinetics, offering insights into Alzheimer's and Parkinson's pathologies.

Applications of GFP-Specific Neutralizing Antibodies

• Enhancing Molecular Imaging Accuracy

Anti-GFP antibodies suppress unintended fluorescence in multiplex assays, improving signal-to-noise ratios. For instance, neutralizing free GFP in serum samples enhances detection sensitivity in circulating tumor cell (CTC) analyses.

• Optimizing Gene Therapy Safety

GFP is widely used to track viral vector delivery in gene therapies. Our antibodies neutralize residual GFP-tagged vectors post-administration, mitigating immune responses and improving therapeutic safety profiles.

• Streamlining Protein Interaction Studies

In co-immunoprecipitation assays, anti-GFP antibodies selectively pull down GFP-tagged proteins while excluding non-target complexes, ensuring accurate interactome mapping.

• Supporting Diagnostic Assay Development

GFP-specific antibodies validate diagnostic kits by confirming the integrity of GFP-labeled probes. In COVID-19 research, they verify spike protein-GFP fusions in neutralization assays, expediting vaccine candidate screening.

• Facilitating High-Content Screening

Automated drug discovery platforms rely on GFP reporters to quantify cellular responses. Neutralizing antibodies terminate fluorescence post-analysis, enabling sequential staining rounds without cross-reactivity.

Our Anti-GFP Neutralizing Antibodies

Creative Biolabs' GFP specific Neutra™ antibody portfolio combines rigorous validation with customizable formats (e.g., Fab fragments, IgG isotypes) to meet diverse experimental demands.

Our GFP-specific antibodies are engineered to selectively bind and neutralize GFP with sub-nanomolar affinity, hence limiting off-target effects. These antibodies excel in:

- Quenching fluorescence: Eliminate background noise in co-localization studies.

- Blocking GFP-receptor interactions: Critical for in vivo studies using GFP-labeled therapeutics.

- Immunodepletion: Remove GFP-fusion proteins from lysates to isolate native complexes. Validated in flow cytometry, super-resolution microscopy, our antibodies ensure reproducibility in high-stakes research.

Contact our team today to discuss your project requirements and request tailored solutions.

REFERENCE

1. Nam, Ki Hyun. "Fluorescent protein-based metal biosensors." Chemosensors 11.4 (2023): 216. Distributed under Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/chemosensors11040216